- 14 June 2013
New gene causing congenital muscular dystrophy identified Prof Francesco Muntoni and an international team of scientists have discovered that mutations in a gene called B-1,3-N-acetylgalactosaminyltransferase 2 can cause congenital muscular dystrophy.
- 7 June 2013
New potential target for treating myotonic dystrophy type 1 Researchers in Illinois have discovered a drug-like molecule which they hope may have the potential to be developed into a treatment for myotonic dystrophy type 1. However, the work is still at a very early stage and it will therefore be some time before
- 17 May 2013
Scientists develop new methods to produce embryonic stem cells Researchers in the USA have developed a new method to generate embryonic stem cells which may bring stem cell treatments a step closer.
- 11 May 2013
New registry for people with FSH muscular dystrophy launched A new patient registry for individuals with facioscapulohumeral (FSH) muscular dystrophy, funded by the Muscular Dystrophy Campaign has been launched today.
- 1 May 2013
Sarepta Therapeutics update Over the past few weeks Sarepta Therapeutics have announced updates about their clinical trials and pre-clinical research into exon skipping technology.
- 16 April 2013
Laboratory visit for our supporters We visited Prof. Matthew Wood's laboratory in Oxford to get an exclusive, behind the scenes update on their exciting research. We were joined on the visit by supporters from around the country who are funding Prof. Wood's research.
- 12 April 2013
GSK announces results of exon skipping trial At a conference in the USA, Glaxosmithkline has announced preliminary results from a phase 2 clinical trial of exon skipping technology in boys with Duchenne muscular dystrophy.
- 8 April 2013
An update on our annual grant round An update on the progress of this year's grant round, which started in October 2012.
- 27 March 2013
Behind the scenes laboratory visit for families Families affected by Duchenne muscular dystrophy saw firsthand the progress Professor George Dickson and his team are making in pioneering work into treatments for Duchenne muscular dystrophy, as they toured their laboratories.
- 23 March 2013
Report from the UK Neuromuscular Translational Research Conference Nearly 200 people gathered in Oxford for the sixth annual UK Neuromuscular Translational Research Conference. with a busy program of talks and posters presented by international experts in the field of neuromuscular diseases.